MENINGOCOCCAL SEPSIS – CASE REPORT
Abstract
Background. Fulminant meningococcemia is a rare but severest manifestation of infection with Neisseria meningitidis. Despite the most advanced treatment the death rate remains between 30–70%. Usually, it occurs in children, while immune system deficiencies are frequently discovered in elderly patients. The incidence of meningococcal infections in Slovenia is about 0.43/100,000 inhabitants and 4.1% of these are in the form of fulminant meningococcal sepsis.
Patients and methods. The paper describes the case of a 17year-old patient with fulminant meningococcal sepsis, which he had already recovered from once before as a child. According to the prognostic factors, the expected mortality was above 75%. Continuous dialysis was implemented in addition to conventional treatment. The patient died due to central nervous system involvement after 10 days.
Conclusions. We propose that the described treatment succeeded in slowing the expected fulminant course of the disease. A disturbance in the patient’s immune system was demonstrated and Neisseria meningitidis W-135 was isolated.
Downloads
References
Marolt-Gomišček M, Radšel-Medvešček A. Infekcijske bolezni. Ljubljana: Tangram, 1992: 67–72.
Čižman M, Gubina M, Paragi M et al. Meningococcal disease in Slovenia (1993–1999): serogroups and susceptibility to antibiotics. Int J Antimicrobial Agents 2001; 17: 27–31.
Apicella MA. Neisseria meningitidis. In: Mandell GL, Douglas RG, Bennett JE, Dolin R eds. Mandell, Douglas, and Bennett’s principles and practice of infectious diseases. 5th ed. Vol. 2. Philadelphia: Livingstone, 2000: 2228–38.
Brantzaeg P. Pathogenesis of meningococcal infections. In: Cartwright K ed. Meningococcal disease. Chichester: John Wiley, 1995: 71–1.
Gardlund B. Prognostic evaluation in meningococcal disease. A retrospective study of 115 cases. Intensive Care Med 1986; 12: 302–7.
Sinclair JF, Skeoch CH, Hallworth D. Prognosis of meningococcal septicaemia. Lancet 1987; 2: 38–8.
Emparanza JI, Aldamiz-Echevarria L, Perez-Yarza EG et al. Prognostic score in acute meningococcemia. Crit Care Med 1988; 16: 168–9.
Niklasson P, Lundberh P, Strandell T. Prognostic factors in meningococcal disease. Scand J Infect Dis 1971; 3: 17–25.
Thomson APJ, Sills JA, Hart CA. Validation of the Glasgow meningococcal septicaemia prognostic score: a 10-year retrospective survey. Crit Care Med 1991; 19: 26–30.
McLeod-Griffiss J. Meningococcal infections. In: Braunwald E, Isselbacher KJ, Petersdorf RG, Wilson JD, Fauci AS eds. Harrison’s principles of internal medicine. 12th ed. Vol. 1, New York: McGraw-Hill, 1991: 590–3.
Lim D, Gewurz A, Lint TF et al. Absence of the sixth component of complement in patients with repeated episodes of meningococcal meningitis. J Pediatr 1976; 89: 42–2.
Alper CA, Abramson N, Johnston RB Jr. Increased susceptibility to infection associated with abnormalities of complement-mediated functions and of the third component of complement (C3). N Engl J Med 1970; 282: 349–9.
Petersen BH, Graham JA, Brooks GF. Human deficiency of the eighth component of complement. The requirement of C8 for serum Neisseria gonorrhoreae bactericidal activity. J Clin Invest 1976; 57: 283–3.
Densen P, Weiler JM, Griffiss JM et al. Familial properdin deficiency and fatal bacteremia. Correction of the bactericidal defect by vaccination. N Engl J Med 1987; 316: 922–2.
Densen P. Complement deficiencies and meningococcal disease. Clin Exp Immunol 1991; 86: Suppl 1: 57–7.
Ellison RT, Kohler PF, Curd JG et al. Prevalence of congenital or acquired complement deficiency in patients with sporadic meningococcal disease. N Engl J Med 1983; 308: 913–3.
Ross SC, Rosenthal PJ, Berberich HM et al. Killing of Neisseria meningitidis by human neutrophils: Implications for normal and complement deficient individuals. J infect Dis 1987; 155: 1266–6.
Kotnik V, Luznik-Bufon T, Schneider PM et al. Molecular, genetic, and functional analysis of homozygous C8β-chain deficiency in two siblings. Immunopharmacology 1997; 38: 215–21.
Kotnik V, Luznik-Bufon T, Schneider P et al. Complement analysis in a family with C8β-chain deficiency. Exp Clin Immunogenet 1997; 14: 62–2.
Lužnik-Bufon T. Prirojene pomanjkljivosti komplementa. Med Razgl 1998; 37: Suppl 5: 131–5.
Haensch R. Haemorrhagische Diathesen. In: Korting G. Dermatologie in Praxis und Klinik. Band III. Stuttgart: Georg Thieme Verlag, 1979: 23.20– 23.21.
Van Deuren M, Santman FW, van Dalen R, Sauerwein RW, Span LFR, van der Meer JWM. Plasma and whole blood exchange in meningococcal sepsis. Clin Infect Dis 1992; 15: 424–30.
Brandtzaeg P, Øvstebø R, Kierulf P. Bacteriemia and compartmentalisation of lipopolysaccharide in meningococcal disease. In: Levin J, Alving CR, Munford R, Redl H eds. Lipopolysaccharides from gene to therapy. New York: Wiley-Liss, 1995: 219–33.
Levin M, Quint PA, Goldstein B et al. Recombinant bactericidal/permeability – increasing protein (rBPI21) as adjunctive treatment for children with severe meningococcal sepsis: a randomised trial. Lancet 2000; 356: 961–7.
The J5 Study group. Treatment of severe infectious purpura in children with human plasma from donors immunised with Escherichia coli J5: a prospective double-blind study. J Infect Dis 1992; 165: 695–701.
Derkx B, Wittes J, McCloskey R. Randomised placebo controlled trial of HA– 1A, a human monoclonal anti-endotoxin antibody in children with meningococcal septic shock. Clin Infect Dis 1999; 28: 770–7.
Pollard AJ, Britto J, Nadel S et al. Emergency management of meningococcal disease. Arch Dis Child 1999; 80: 290–6.
Browne GJ, Ryan JM, McIntyre P. Evaluation of a protocol for selective empiric treatment of fever without localising signs. Arch Dis Child 1997; 76: 129–33.
Smith OP et al. Use of protein C-concentrate, heparin, and haemodiafiltration in meningococcus – induced purpura fulminans. Lancet 1997; 350: 1590–0.
Esmon CT. The roles of protein C and thrombomodulin in the regulation of blood coagulation. J Biol Chem 1989; 264: 4743–3.
Rivard GE et al. Treatment of purpura fulminans in meningococcemia with protein C concentrate. J Pediatr 1995; 126: 646–6.
Kumar A, Kanagasundaram NS, Collyns TA et al. Plasma exchange and haemodiafiltration in fulminant meningococcal sepsis. Nephro Dial Transplant 1998; 13: 484–7.
Sakellariou G. Plasmapheresis as a therapy in specific forms of acute renal failure. Nephrol Dial Transplant 1994; 9: 210–18.
Bjorvatn B, Bjertnaes L, Fadnes HO et al. Meningococcal septicaemia treated with combined plasmapheresis and leucopheresis or with blood exchange. British Medical Journal 1984; 288: 439–41.
The Author transfers to the Publisher (Zdravniški vestnik/Slovenian Medical Journal) all economic copyrights following form Article 22 of the Slovene Copyright and Related Rights Act (ZASP), including the right of reproduction, the right of distribution, the rental right, the right of public performance, the right of public transmission, the right of public communication by means of phonograms and videograms, the right of public presentation, the right of broadcasting, the right of rebroadcasting, the right of secondary broadcasting, the right of communication to the public, the right of transformation, the right of audiovisual adaptation and all other rights of the author according to ZASP.
The aforementioned rights are transferred non-exclusively, for an unlimited number of editions, for the term of the statutory
The Author can make use of his work himself or transfer subjective rights to others only after 3 months from date of first publishing in the journal Zdravniški vestnik/Slovenian Medical Journal.
The Publisher (Zdravniški vestnik/Slovenian Medical Journal) has the right to transfer the rights, acquired parties without explicit consent of the Author.
The Author consents that the Article be published under the Creative Commons BY-NC 4.0 (attribution-non-commercial) or comparable licence.
